Millendo Therapeutics

Why Robinhood?

You can watch MLND and buy or sell other stocks, options, and ETFs commission-free!

About MLND

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

CEO

Stephen R. Brady

CEOStephen R. Brady

Employees

Employees17

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

Employees

Employees17

MLND Key Statistics

Market cap

13.25M

Market cap13.25M

Price-Earnings ratio

-0.34

Price-Earnings ratio-0.34

Dividend yield

—

Dividend yield—

Average volume

10.20K

Average volume10.20K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$4.55

52 Week high$4.55

52 Week low

$1.06

52 Week low$1.06

MLND Earnings

-$0.44

-$0.29

-$0.15

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Estimated— per share

Actual

Expected Nov 8, Pre-Market

ActualExpected Nov 8, Pre-Market

Millendo Therapeutics

Why Robinhood?

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Show more

MLND Key Statistics

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.